Stephen Parker

Stephen Parker

Chairman at BIODEXA PHARMACEUTICALS PLC

Net worth: 35 271 $ as of 2024-04-29

65 year
Health Technology
Finance
Commercial Services

Profile

Stephen B.
Parker
founded UK Stem Cell Foundation.
Dr. Parker also currently works at Sareum Holdings Plc, as Non-Executive Chairman from 2016, Biodexa Pharmaceuticals Plc, as Non-Executive Chairman from 2022, Drishti Discoveries Ltd., as Chairman from 2021, Sareum Ltd., as Director, Sp2 Consulting Ltd., as Director, Eternans Ltd., as Non-Executive Director from 2019, Sp2 Asset Management Ltd., as Director from 2018, and Celtic Pharma Management LP, as Partner from 2005.
Dr. Parker also formerly worked at Argent BioPharma Ltd., as Non-Executive Chairman in 2023, Physiomics Plc, as Non-Executive Chairman in 2005, Ah Animal Healthcare Ltd., as Chairman, Liverpool Chirochem Ltd., as Chairman from 2017 to 2018, Xenova Group Plc, as Director, Silence Therapeutics Plc, as Independent Non-Executive Director from 2017 to 2019, GCA Altium Ltd., as Director, Celtic Pharma Development UK Plc, as Director, Novacta Biosystems Ltd., as Director, PBB Devices Ltd., as Director, Xenova Ltd., as Director, Gammadelta Therapeutics Ltd., as Non-Executive Director, Albucasis Ltd., as Director from 2013 to 2019, Celtic Pharma GP Ltd., as Director, Apax Partners LLP, as Principal, Celtic Pharma Holdings Advisors LLP, as Principal, Pa Consulting Group Ltd., as Consultant, Warburg Group Plc, as Principal, Oxford GlycoSciences Plc, as Chief Financial Officer in 2002, Barings Plc, as Principal, Beehive Capital LLP, as Partner, and Bedford Royalties Ltd., as Head-Partner Network, Research & Development.
Dr. Parker received his doctorate degree from the University of Oxford, undergraduate degree from the University of East Anglia, and Masters Business Admin degree from Bayes Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-27 116,158 ( 0.11% ) 35 271 $ 2024-04-29

Stephen Parker active positions

CompaniesPositionStart
BIODEXA PHARMACEUTICALS PLC Chairman 2022-06-19
SAREUM HOLDINGS PLC Chairman 2016-05-16
Sp2 Consulting Ltd. Director/Board Member -
Eternans Ltd. Director/Board Member 2019-06-30
Chairman 2020-12-31
Director/Board Member -
Sp2 Asset Management Ltd. Director/Board Member 2018-08-31
Private Equity Investor 2005-03-31
All active positions of Stephen Parker

Former positions of Stephen Parker

CompaniesPositionEnd
ARGENT BIOPHARMA LIMITED Chairman 2023-11-30
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Stephen Parker's experience

Training of Stephen Parker

University of Oxford Doctorate Degree
University of East Anglia Undergraduate Degree
Bayes Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephen Parker's experience

Connections

82

1st degree connections

33

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
SAREUM HOLDINGS PLC

Miscellaneous

ARGENT BIOPHARMA LIMITED

Health Technology

SILENCE THERAPEUTICS PLC

Commercial Services

PHYSIOMICS PLC

Commercial Services

BIODEXA PHARMACEUTICALS PLC

Health Technology

Private companies25

Commercial Services

Finance

Finance

Commercial Services

Warburg Group Plc

Finance

Finance

Health Technology

Finance

Finance

Finance

UK Stem Cell Foundation

Miscellaneous

Health Technology

Finance

Health Technology

Retail Trade

Celtic Pharma GP Ltd.

Health Technology

Health Technology

Sp2 Consulting Ltd.

Health Technology

Health Technology

Eternans Ltd.

Health Technology

Sp2 Asset Management Ltd.

Xenova Ltd.

See company connections
  1. Stock Market
  2. Insiders
  3. Stephen Parker
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW